Stock Comparison
GH vs TMO
Guardant Health Inc and Thermo Fisher Scientific Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$21.57B
$218.35B
P/E (TTM)
—
31.8
Forward P/E
—
23.5
Price/Sales
18.2
4.7
Price/Book
53.1
4.2
EV/EBITDA
-5.2
21.3
Dividend Yield
—
0.30%
Profitability
Net Margin
-40.10%
15.18%
Operating Margin
-41.43%
17.76%
Return on Equity
-4584.00%
13.50%
Return on Assets
-18.10%
5.13%
Growth (YoY)
Revenue Growth
44.30%
10.50%
Earnings Growth
0.00%
9.40%
Price & Risk
Beta
1.6
0.8
52-Week High
$170.77
$638.80
52-Week Low
$54.79
$438.34
Analyst Target
$194.29
$631.42
Compare GH and TMO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.